IP Library Patent Application 18386194
Patent Application
App. No. 18/386,194

Systems, Methods, Mediums, and Apparatuses for Capturing Medications and Medication Usage

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/386,194
Abstract

Systems, methods, non-transitory computer-readable mediums, and/or apparatuses are provided for determining a medication used by a patient. Label information for a medication may be determined. A source national drug code (NDC) associated with the medication may be determined. The source NDC may be validated. A product NDC and a normalized identifier may be determined. A brand name associated with the medication may be determined. One or more active ingredients associated with the brand name may be determined. A drug display name may be determined. The drug display name and active ingredient information for the one or more active ingredients may be displayed. A summary indicating an amount of the active ingredient may be displayed, for example, based on a medication diary.

Claims (57)

1 . A device for determining a medication used by a patient, the device comprising:

a processor, the processor configured to:

determine label information for a medication;

determine a source national drug code (NDC) associated with the medication using the label information;

send a first message to a first server, wherein the first message indicates a request for a validation of the source NDC;

receive a second message from the first server, wherein the second message indicates the source NDC is valid, indicates a product NDC, and indicates a normalized identifier;

determine a brand name associated with the medication using the product NDC;

determine one or more active ingredients associated with the brand name using the normalized identifier;

determine a drug display name using the brand name and the one or more active ingredients;

determine active ingredient information for the one or more active ingredients; and

display the drug display name and the active ingredient information to a user.

2 . The device of claim 1 , wherein the normalized identifier is a RxNorm concept unique identifier (RxCUI).

3 . The device of claim 1 , wherein the product NDC comprises a labeler code and a product code.

4 . The device of claim 1 , wherein the source NDC is a package NDC, and wherein the package NDC comprises a labeler code, a product code, and a package code.

5 . The device of claim 1 , wherein the source NDC comprises a labeler code, a product code, and a package code, and wherein the product NDC comprises the labeler code and the product code.

6 . The device of claim 1 , wherein the processor is configured to determine the label information for the medication by receiving data from a user, wherein the data includes at least one of the source NDC, an active ingredient, a brand name, an image, or a video.

7 . The device of claim 1 , wherein the processor is configured to determine the brand name using the product NDC by:

sending a brand name request message to a second server, wherein the brand name request message indicates a request for a brand name associated with the product NDC; and

receiving a brand name response message from the second server, wherein the brand name response message indicates the brand name.

8 . The device of claim 1 , wherein the processor is configured to determine the one or more active ingredients associated with the brand name by:

sending an ingredient request message to the first server, wherein the ingredient request message indicates a request for one or more active ingredients associated with the normalized identifier;

receive an ingredient response message from the first server, wherein the ingredient response message indicates the normalized identifier and indicates one or more active ingredients; and

store the one or more active ingredients within a database such that the one or more active ingredients are associated with the brand name.

9 . A method performed by a device for determining a medication used by a patient, the method comprising:

determining label information for a medication;

determining a source national drug code (NDC) associated with the medication using the label information;

sending a first message to a first server, wherein the first message indicates a request for a validation of the source NDC;

receiving a second message from the first server, wherein the second message indicates the source NDC is valid, indicates a product NDC, and indicates a normalized identifier;

determining a brand name associated with the medication using the product NDC;

determining one or more active ingredients associated with the brand name using the normalized identifier;

determining a drug display name using the brand name and the one or more active ingredients;

determining active ingredient information for the one or more active ingredients; and

displaying the drug display name and the active ingredient information to a user.

10 . The method of claim 9 , wherein the normalized identifier is a RxNorm concept unique identifier (RxCUI).

11 . The method of claim 9 , wherein the product NDC comprises a labeler code and a product code.

12 . The method of claim 9 , wherein the source NDC is a package NDC, and wherein the package NDC comprises a labeler code, a product code, and a package code.

13 . The method of claim 9 , wherein the source NDC comprises a labeler code, a product code, and a package code, and wherein the product NDC comprises the labeler code and the product code.

14 . The method of claim 9 , wherein determining the label information for the medication comprises receiving data from a user, wherein the data includes at least one of the source NDC, an active ingredient, a brand name, an image, or a video.

15 . A non-transitory computer-readable medium storing processor-executable instructions comprising:

determining an image or a video of a medication label; and

determining a source national drug code (NDC) from the image, wherein the source NDC is associated with the medication label;

sending a first message to a first server, wherein the first message indicates a request for a validation of the source NDC;

receiving a second message from the first server, wherein the second message indicates the source NDC is valid, indicates a product NDC, and indicates a normalized identifier;

determining a brand name associated with the medication using the product NDC;

determining one or more active ingredients associated with the brand name using the normalized identifier;

determining a drug display name using the brand name and the one or more active ingredients;

determining active ingredient information for the one or more active ingredients; and

displaying the drug display name and the active ingredient information to a user.

16 . The non-transitory computer-readable medium of claim 15 , wherein processor-executable instructions for determining the drug display name using the brand name and the one or more active ingredients comprises:

determining a prescribable synonym name for at least an active ingredient of the one or more active ingredients; and

generating the drug display name by combining the brand name with the prescribable synonym name.

17 . The non-transitory computer-readable medium of claim 15 , wherein the processor-executable instructions for determining the active ingredient information for the one or more active ingredients comprises:

sending an active ingredient information request to a third server, wherein the active ingredient information request indicates at least one of a structured product labeling identification (SPL ID) or the normalized identifier; and

receiving an active ingredient information response, wherein the active ingredient information response indicates an active ingredient and indicates at least one of a warning, a direction regarding the active ingredient, or a usage direction, or a drug interaction warning.

18 . The non-transitory computer-readable medium of claim 15 , wherein the normalized identifier is a RxNorm concept unique identifier (RxCUI).

19 . The non-transitory computer-readable medium of claim 15 , wherein the product NDC comprises a labeler code and a product code.

20 . The non-transitory computer-readable medium of claim 15 , wherein the source NDC is a package NDC, and wherein the package NDC comprises a labeler code, a product code, and a package code.

Assignments (1)
CHANGE OF NAME Recorded Oct 28, 2024
From: JOHNSON & JOHNSON CONSUMER INC.
To: KENVUE BRANDS LLC
Reel/Frame 069267/0143 →